CAPE was able to attenuate the PGPS-induced colitis through its ability to inhibit the nuclear factor-κB (NF-κB) pathway, by reducing the production of proinflammatory cytokines and by induction of apoptosis in macrophages [72]. This evidence concerns the gene NFKB1 and colitis.